Skip to main content
bioRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search
New Results

Substantial Differences in SARS-CoV-2 Antibody Responses Elicited by Natural Infection and mRNA Vaccination

Rafael Assis, Aarti Jain, Rie Nakajima, Al Jasinskas, Saahir Kahn, Anton Palma, View ORCID ProfileDaniel M. Parker, Anthony Chau, Amanda Leung, Christina Grabar, Fjolla Muqolli, Ghali Khalil, Jessica Colin Escobar, Jenny Ventura, D. Huw Davies, Bruce Albala, Bernadette Boden-Albala, Sebastian Schubl, Philip L. Felgner
doi: https://doi.org/10.1101/2021.04.15.440089
Rafael Assis
University of California Irvine, School of Medicine and the Vaccine R&D Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aarti Jain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rie Nakajima
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Al Jasinskas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Saahir Kahn
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anton Palma
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel M. Parker
5Department of Population Health Disease Prevention and Department of Epidemiology and Biostatistics
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Daniel M. Parker
Anthony Chau
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amanda Leung
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christina Grabar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fjolla Muqolli
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ghali Khalil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jessica Colin Escobar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jenny Ventura
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D. Huw Davies
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bruce Albala
2University of California Irvine, School of Medicine, Department of Neurology
3Center for Clinical Research
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bernadette Boden-Albala
2University of California Irvine, School of Medicine, Department of Neurology
4University of California Irvine, Program in Public Health, Department of Health Society and Behavior
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sebastian Schubl
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philip L. Felgner
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: pfelgner@hs.uci.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Preview PDF
Loading

Abstract

We analyzed data from two ongoing serologic surveys, a longitudinal cohort of health care workers (HCW) from the University of California Irvine Medical Center (Orange County, CA, USA), collected from May and December 2020 through March 2021, and a cross sectional county-wide study in July 2020 (actOC; Orange County, CA) and a more focused community study in the city of Santa Ana (Santa Ana Cares; Orange County, CA, USA), collected in December 2020 - in order to compare the antibody responses to SARS-CoV-2 natural infection and vaccination. In addition, we serially tested 9 volunteers at multiple time points to analyze the time course of vaccine-induced antibody response in more detail. In May 2020, 1060 HCW were enrolled and had finger stick samples collected. Finger stick samples were again collected in December 2020, before vaccination, as well as January, February and March 2021 during vaccination campaign. A total of 8,729 finger stick blood specimens were probed and analyzed for IgG and IgM antibodies using a coronavirus antigen microarray (COVAM).The microarray contained 10 SARS-CoV-2 antigens including nucleocapid protein (NP) and several varying fragments of the spike protein, as well as 4 SARS, 3 MERS, 12 Common CoV, and 8 Influenza antigens.Based on a random forest based prediction algorithm, between May and December, prior to vaccine rollout, we observed that seropositivity in the HCW cohort increased from 4.5% to 13%. An intensive vaccination campaign with mRNA vaccines was initiated on December 16, 2020 and 6,724 healthcare workers were vaccinated within 3 weeks. The observed seropositivity of the HCW specimens taken in the last week of January 2021 jumped to 78%, and by the last week in February it reached 93%, and peaked at 98% seropositive in March. The antibody profile induced by natural exposure differed from the profile induced after mRNA vaccination. Messenger RNA vaccines induced elevated antibody (Ab) reactivity levels against the Receptor Binding Domain (RBD) domain of SARS-CoV-2 spike, and cross-reactive responses against SARS and MERS RBD domains. Nucleocapsid protein (NP), which is an immunodominant antigen induced after natural exposure, is not present in the vaccine and can be used as a biomarker of past exposure. The results show that naturally-exposed individuals mount a stronger anti-spike response upon vaccination than individuals that were not previously exposed. Longitudinal specimens taken at approximately weekly intervals from 9 individuals show variation in the response to the mRNA vaccine, with some showing a vigorous response to the first dose (prime) and others requiring a subsequent dose (boost) to reach high anti-SARS-CoV-2 levels. Antibody titers determined by serial dilution of the specimens were used to accurately compare antibody levels in these samples. mRNA vaccinees after the boost have higher Ab titers (up to 10 times higher) than convalescent plasmas from donors who recovered from natural infection. The results of this study exemplify the time course and outcomes expected from similar mRNA mass vaccination campaigns conducted in other institutions.

Competing Interest Statement

The coronavirus antigen microarray is intellectual property of the Regents of the University of California that is licensed for commercialization to Nanommune Inc. (Irvine, CA), a private company for which Philip L. Felgner is the largest shareholder and several co-authors (Assis, Jain, Nakajima, Jasinskas, Davies, and Khan) also own shares. Nanommune Inc. has a business partnership with Sino Biological Inc. (Beijing, China) which expressed and purified the antigens used in this study, The other authors have no competing interests

Copyright 
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted April 19, 2021.
Download PDF

Supplementary Material

Email

Thank you for your interest in spreading the word about bioRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Substantial Differences in SARS-CoV-2 Antibody Responses Elicited by Natural Infection and mRNA Vaccination
(Your Name) has forwarded a page to you from bioRxiv
(Your Name) thought you would like to see this page from the bioRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Substantial Differences in SARS-CoV-2 Antibody Responses Elicited by Natural Infection and mRNA Vaccination
Rafael Assis, Aarti Jain, Rie Nakajima, Al Jasinskas, Saahir Kahn, Anton Palma, Daniel M. Parker, Anthony Chau, Amanda Leung, Christina Grabar, Fjolla Muqolli, Ghali Khalil, Jessica Colin Escobar, Jenny Ventura, D. Huw Davies, Bruce Albala, Bernadette Boden-Albala, Sebastian Schubl, Philip L. Felgner
bioRxiv 2021.04.15.440089; doi: https://doi.org/10.1101/2021.04.15.440089
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Substantial Differences in SARS-CoV-2 Antibody Responses Elicited by Natural Infection and mRNA Vaccination
Rafael Assis, Aarti Jain, Rie Nakajima, Al Jasinskas, Saahir Kahn, Anton Palma, Daniel M. Parker, Anthony Chau, Amanda Leung, Christina Grabar, Fjolla Muqolli, Ghali Khalil, Jessica Colin Escobar, Jenny Ventura, D. Huw Davies, Bruce Albala, Bernadette Boden-Albala, Sebastian Schubl, Philip L. Felgner
bioRxiv 2021.04.15.440089; doi: https://doi.org/10.1101/2021.04.15.440089

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Immunology
Subject Areas
All Articles
  • Animal Behavior and Cognition (4111)
  • Biochemistry (8814)
  • Bioengineering (6518)
  • Bioinformatics (23458)
  • Biophysics (11789)
  • Cancer Biology (9206)
  • Cell Biology (13320)
  • Clinical Trials (138)
  • Developmental Biology (7434)
  • Ecology (11408)
  • Epidemiology (2066)
  • Evolutionary Biology (15146)
  • Genetics (10435)
  • Genomics (14042)
  • Immunology (9170)
  • Microbiology (22152)
  • Molecular Biology (8811)
  • Neuroscience (47563)
  • Paleontology (350)
  • Pathology (1428)
  • Pharmacology and Toxicology (2491)
  • Physiology (3730)
  • Plant Biology (8079)
  • Scientific Communication and Education (1437)
  • Synthetic Biology (2220)
  • Systems Biology (6037)
  • Zoology (1253)